Azirkitug: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

10

Conditions studied

11

US states with sites

6

Countries

Phase breakdown

Phase 1 1

Conditions being studied

Condition	Trials
Breast cancer	1
Colorectal cancer	1
Gastric/Esophageal Cancer	1
Head and Neck Squamous Cell Carcinoma	1
High-Grade Serous Ovarian Cancer	1
Lung cancer	1
Micro Satellite Stable Colorectal Cancer	1
Non-Small Cell Lung Cancer	1
Pancreatic Cancer	1
Triple Negative Breast Cancer	1

Recruiting trials involving Azirkitug

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
NCT05005403 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 48 locations

Common questions

How many recruiting trials involve Azirkitug?

1 recruiting trial across 10 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.